Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

spironolactone, althiazide drug combination MeSH Supplementary Concept Data 2025


MeSH Supplementary
spironolactone, althiazide drug combination
Unique ID
C026063
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C026063
Entry Term(s)
Aldactacine
aldactazine
practazin
prinactizide
spiroctazine
Registry Numbers
76270-06-9
0
CAS Type 1 Name
Pregn-4-ene-21-carboxylic acid, 7-(acetylthio)-17-hydroxy-3-oxo-, gamma-lactone, (7alpha,17alpha)-, mixt. with 6-chloro-3,4-dihydro-3-((2-propenylthio)methyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
Heading Mapped to
Drug Combinations
*Spironolactone
*Sulfonamides
Frequency
13
Note
combination of spironolactone and althiazide for treatment of benign essential hypertension
Source
J Int Med Res 1980;8(3):199
Date of Entry
1980/08/28
Revision Date
2009/09/09
spironolactone, althiazide drug combination Preferred
practazin Narrower
prinactizide Narrower
spiroctazine Narrower
Aldactacine Narrower
page delivered in 0.002s